Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients
Status:
Unknown status
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
Hypertensive patients with moderate hypertension have a risk to develop cardiovascular events
of 15-20% over a period of 10 years. It is important to reach quickly the advised target, but
often this result can be obtained with a combination therapy. Some evidences demonstrate
sartans and calcium channels blockers can be very useful and safe, but it is also important
to verify which association can give side effects or give some pharmacokinetic interactions
that can negatively influence the clinical combination efficacy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pavia
Treatments:
Amlodipine Amlodipine, Valsartan Drug Combination Losartan Valsartan